Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LARGE anticorps (AA 35-142)

Cet anticorps Souris Monoclonal détecte spécifiquement LARGE dans WB et FACS. Il présente une réactivité envers Humain.
N° du produit ABIN5541530

Aperçu rapide pour LARGE anticorps (AA 35-142) (ABIN5541530)

Antigène

Voir toutes LARGE Anticorps
LARGE (Like-Glycosyltransferase (LARGE))

Reactivité

  • 9
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Humain

Hôte

  • 6
  • 2
  • 1
Souris

Clonalité

  • 8
  • 1
Monoclonal

Conjugué

  • 8
  • 1
Cet anticorp LARGE est non-conjugé

Application

  • 7
  • 3
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS)

Clone

LARGE-02
  • Épitope

    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 35-142

    Specificité

    This antibody recognizes human LARGE1, a glycosyltransferase localizing mainly to the Golgi apparatus. Crossreactivity with LARGE2 was not determined.

    Purification

    Protein-A affinity chromatography (> 95% pure by SDS-PAGE)

    Immunogène

    Recombinant fragment of human LARGE1 (amino acids 35-142)

    Isotype

    IgG2b
  • Indications d'application

    Flow cytometry. Western blot.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    95 % pure by SDS-PAGE) Buffer System: Phosphate buffered saline (PBS) Preservatives: 15 mM sodium azide, approx. pH 7.4

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Store undiluted at 2-8°C. DO NOT FREEZE! Shelf life: one year from despatch.

    Date de péremption

    12 months
  • Antigène

    LARGE (Like-Glycosyltransferase (LARGE))

    Autre désignation

    large

    Sujet

    LARGE1 serves as a glycosyltransferase which participates in glycosylation of the muscle membrane protein alpha-dystroglycan. Mutations of LARGE1 lead to hypoglycosylation of alpha-dystroglycan and cause congenital muscular dystrophy (MDC1D) associated with severe mental retardation. Altered alpha-dystroglycan glycosylation may also play a role in cancer, as hypoglycosylation of the protein and loss of laminin binding have been demonstrated in invasive carcinoma cells.

    UniProt

    O95461
Vous êtes ici:
Chat with us!